Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1233 ARTÍCULOS , VIENDO DEL 1006 AL 1020
Alzheimer's disease pathogenesis: Is there a role for folate?
Robinson N, Grabowski P, Rehman I.
Mech Ageing Dev. 2018 Sep;174:86-94. doi: 10.1016/j.mad.2017.10.001. Epub 2017 Oct 13.
A decay of the adaptive capacity of the unfolded protein response exacerbates Alzheimer's disease
Gerakis Y, Hetz C.
Neurobiol Aging. 2018 Mar;63:162-164. doi: 10.1016/j.neurobiolaging.2017.09.012. Epub 2017 Sep 22.
Amyloid and immune homeostasis
Wang YH, Zhang YG.
Immunobiology. 2018 Mar;223(3):288-293. doi: 10.1016/j.imbio.2017.10.038. Epub 2017 Oct 16.
Reprogramming energetic metabolism in Alzheimer's disease
Vallée A, Lecarpentier Y, Guillevin R, Vallée JN.
Life Sci. 2018 Jan 15;193:141-152. doi: 10.1016/j.lfs.2017.10.033. Epub 2017 Oct 25.
Eggert S, Thomas C, Kins S, Hermey G.
Mol Neurobiol. 2018 Jul;55(7):5809-5829. doi: 10.1007/s12035-017-0806-x. Epub 2017 Oct 27.
Oxidative stress and the amyloid beta peptide in Alzheimer's disease
Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F.
Redox Biol. 2018 Apr;14:450-464. doi: 10.1016/j.redox.2017.10.014. Epub 2017 Oct 18.
How efficient are rodent models for Alzheimer's disease drug discovery?
Guo B, Zhou Q.
Expert Opin Drug Discov. 2018 Feb;13(2):113-115. doi: 10.1080/17460441.2018.1398730. Epub 2017 Oct 31.
Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus
Van Erum J, Van Dam D, De Deyn PP.
Sleep Med Rev. 2018 Aug;40:17-27. doi: 10.1016/j.smrv.2017.07.005. Epub 2017 Jul 28.
Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis
Cheng J, Liu HP, Lee CC, Chen MY, Lin WY, Tsai FJ.
Neurol Sci. 2018 Feb;39(2):267-274. doi: 10.1007/s10072-017-3166-4. Epub 2017 Nov 4.
Simon L, Delaunay P, Martinez JP, Hubiche T, Del Giudice P.
Clin Exp Dermatol. 2018 Apr;43(3):342-344. doi: 10.1111/ced.13291. Epub 2017 Nov 6.
The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis
Sun J, Roy S.
Dev Neurobiol. 2018 Mar;78(3):340-347. doi: 10.1002/dneu.22556. Epub 2017 Nov 13.
Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases
Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, Nguyen T, Malphrus KG, Lincoln S, Carrasquillo MM, Ho C, Chakrabarty P, Strickland S, Murray ME, Swarup V, Geschwind DH, Seyfried NT, Dammer EB, Lah JJ, Levey AI, Golde TE, Funk C, Li H, Price ND, Petersen RC, Graff-Radford NR, Younkin SG, Dickson DW, Crook JR, Asmann YW, Ertekin-Taner N.
Alzheimers Dement. 2018 Mar;14(3):352-366. doi: 10.1016/j.jalz.2017.09.012. Epub 2017 Oct 31.
A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient
Chao PC, Li JC, Yeh TC, Yeh CB.
Aust N Z J Psychiatry. 2018 Feb;52(2):204-205. doi: 10.1177/0004867417741983. Epub 2017 Nov 9.
Crosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease
Santos LE, Ferreira ST.
Neuropharmacology. 2018 Jul 1;136(Pt B):350-360. doi: 10.1016/j.neuropharm.2017.11.016. Epub 2017 Nov 10.
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira MNN, Lima-Filho RAS, De Felice FG.
Neuropharmacology. 2018 Jul 1;136(Pt B):160-171. doi: 10.1016/j.neuropharm.2017.11.014. Epub 2017 Nov 10.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.